1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Asia-Pacific Haematology Market Outlook to 2021

Asia-Pacific Haematology Market Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 179 pages

Asia-Pacific Haematology Market Outlook to 2021

Summary

GlobalData’s new report, "Asia-Pacific Haematology Market Outlook to 2021", provides key market data on the Asia-Pacific Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Haematology market.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Haematology market.
- Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Asia-Pacific Haematology Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Haematology Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 11
3 Haematology Market, Asia-Pacific 14
3.1 Haematology Market, Asia-Pacific, Revenue ($m), 2007-2021 14
3.2 Haematology Market, Asia-Pacific, Category Comparison by Revenue ($m), 2007-2021 16
3.3 Haematology Market, Asia-Pacific, Revenue ($m), 2007-2014 18
3.4 Haematology Market, Asia-Pacific, Revenue ($m), 2014-2021 20
3.5 Haematology Market, Asia-Pacific, Company Share by Revenue ($m), 2014 22
4 Haematology Market, Australia 24
4.1 Haematology Market, Australia, Revenue ($m), 2007-2014 24
4.2 Haematology Market, Australia, Revenue ($m), 2014-2021 26
4.2.1 Haematology Cell Counters Market, Australia, Revenue ($m), by Segment, 2007-2014 28
4.2.2 Haematology Rapid Tests and POC Market, Australia, Revenue ($m), by Segment, 2007-2014 30
4.2.3 Haematology Reagents Market, Australia, Revenue ($m), by Segment, 2007-2014 32
4.2.4 Haemostasis Market, Australia, Revenue ($m), by Segment, 2007-2014 34
4.2.5 Immunohaematology Market, Australia, Revenue ($m), by Segment, 2007-2014 36
4.2.6 Haematology Cell Counters Market, Australia, Revenue ($m), by Segment, 2014-2021 38
4.2.7 Haematology Rapid Tests and POC Market, Australia, Revenue ($m), by Segment, 2014-2021 40
4.2.8 Haematology Reagents Market, Australia, Revenue ($m), by Segment, 2014-2021 42
4.2.9 Haemostasis Market, Australia, Revenue ($m), by Segment, 2014-2021 44
4.2.10 Immunohaematology Market, Australia, Revenue ($m), by Segment, 2014-2021 46
4.3 Haematology Market, Australia, Distribution Share by Revenue ($m), 2013-2014 48
4.4 Haematology Market, Australia, Company Share by Revenue ($m), 2014 49
5 Haematology Market, China 51
5.1 Haematology Market, China, Revenue ($m), 2007-2014 51
5.2 Haematology Market, China, Revenue ($m), 2014-2021 53
5.2.1 Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2007-2014 55
5.2.2 Haematology Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2007-2014 57
5.2.3 Haematology Reagents Market, China, Revenue ($m), by Segment, 2007-2014 59
5.2.4 Haemostasis Market, China, Revenue ($m), by Segment, 2007-2014 61
5.2.5 Immunohaematology Market, China, Revenue ($m), by Segment, 2007-2014 63
5.2.6 Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2014-2021 65
5.2.7 Haematology Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2014-2021 67
5.2.8 Haematology Reagents Market, China, Revenue ($m), by Segment, 2014-2021 69
5.2.9 Haemostasis Market, China, Revenue ($m), by Segment, 2014-2021 71
5.2.10 Immunohaematology Market, China, Revenue ($m), by Segment, 2014-2021 73
5.3 Haematology Market, China, Distribution Share by Revenue ($m), 2013-2014 75
5.4 Haematology Market, China, Company Share by Revenue ($m), 2014 76
6 Haematology Market, India 78
6.1 Haematology Market, India, Revenue ($m), 2007-2014 78
6.2 Haematology Market, India, Revenue ($m), 2014-2021 80
6.2.1 Haematology Cell Counters Market, India, Revenue ($m), by Segment, 2007-2014 82
6.2.2 Haematology Rapid Tests and POC Market, India, Revenue ($m), by Segment, 2007-2014 84
6.2.3 Haematology Reagents Market, India, Revenue ($m), by Segment, 2007-2014 86
6.2.4 Haemostasis Market, India, Revenue ($m), by Segment, 2007-2014 88
6.2.5 Immunohaematology Market, India, Revenue ($m), by Segment, 2007-2014 90
6.2.6 Haematology Cell Counters Market, India, Revenue ($m), by Segment, 2014-2021 92
6.2.7 Haematology Rapid Tests and POC Market, India, Revenue ($m), by Segment, 2014-2021 94
6.2.8 Haematology Reagents Market, India, Revenue ($m), by Segment, 2014-2021 96
6.2.9 Haemostasis Market, India, Revenue ($m), by Segment, 2014-2021 98
6.2.10 Immunohaematology Market, India, Revenue ($m), by Segment, 2014-2021 100
6.3 Haematology Market, India, Distribution Share by Revenue ($m), 2013-2014 102
6.4 Haematology Market, India, Company Share by Revenue ($m), 2014 103
7 Haematology Market, Japan 105
7.1 Haematology Market, Japan, Revenue ($m), 2007-2014 105
7.2 Haematology Market, Japan, Revenue ($m), 2014-2021 107
7.2.1 Haematology Cell Counters Market, Japan, Revenue ($m), by Segment, 2007-2014 109
7.2.2 Haematology Rapid Tests and POC Market, Japan, Revenue ($m), by Segment, 2007-2014 111
7.2.3 Haematology Reagents Market, Japan, Revenue ($m), by Segment, 2007-2014 113
7.2.4 Haemostasis Market, Japan, Revenue ($m), by Segment, 2007-2014 115
7.2.5 Immunohaematology Market, Japan, Revenue ($m), by Segment, 2007-2014 117
7.2.6 Haematology Cell Counters Market, Japan, Revenue ($m), by Segment, 2014-2021 119
7.2.7 Haematology Rapid Tests and POC Market, Japan, Revenue ($m), by Segment, 2014-2021 121
7.2.8 Haematology Reagents Market, Japan, Revenue ($m), by Segment, 2014-2021 123
7.2.9 Haemostasis Market, Japan, Revenue ($m), by Segment, 2014-2021 125
7.2.10 Immunohaematology Market, Japan, Revenue ($m), by Segment, 2014-2021 127
7.3 Haematology Market, Japan, Distribution Share by Revenue ($m), 2013-2014 129
7.4 Haematology Market, Japan, Company Share by Revenue ($m), 2014 130
8 Haematology Market, South Korea 132
8.1 Haematology Market, South Korea, Revenue ($m), 2007-2014 132
8.2 Haematology Market, South Korea, Revenue ($m), 2014-2021 134
8.2.1 Haematology Cell Counters Market, South Korea, Revenue ($m), by Segment, 2007-2014 136
8.2.2 Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), by Segment, 2007-2014 138
8.2.3 Haematology Reagents Market, South Korea, Revenue ($m), by Segment, 2007-2014 140
8.2.4 Haemostasis Market, South Korea, Revenue ($m), by Segment, 2007-2014 142
8.2.5 Immunohaematology Market, South Korea, Revenue ($m), by Segment, 2007-2014 144
8.2.6 Haematology Cell Counters Market, South Korea, Revenue ($m), by Segment, 2014-2021 146
8.2.7 Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), by Segment, 2014-2021 148
8.2.8 Haematology Reagents Market, South Korea, Revenue ($m), by Segment, 2014-2021 150
8.2.9 Haemostasis Market, South Korea, Revenue ($m), by Segment, 2014-2021 152
8.2.10 Immunohaematology Market, South Korea, Revenue ($m), by Segment, 2014-2021 154
8.3 Haematology Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 156
8.4 Haematology Market, South Korea, Company Share by Revenue ($m), 2014 157
9 Overview of Key Companies in Asia-Pacific Haematology Market 159
9.1 Sysmex Corporation 159
9.1.1 Company Overview 159
9.2 Siemens Healthcare 159
9.2.1 Company Overview 159
9.3 Danaher Corporation 159
9.3.1 Company Overview 159
9.4 F. Hoffmann-La Roche Ltd. 159
9.4.1 Company Overview 159
9.5 Horiba, Ltd. 160
9.5.1 Company Overview 160
9.6 Abbott Laboratories 160
9.6.1 Company Overview 160
9.7 Nihon Kohden Corporation 160
9.7.1 Company Overview 160
9.8 Transasia Bio-Medicals Ltd. 161
9.8.1 Company Overview 161
9.9 Mindray Medical International Limited 161
9.9.1 Company Overview 161
9.10 bioMerieux S.A. 161
9.10.1 Company Overview 161
9.11 Bio-Rad Laboratories, Inc. 162
9.11.1 Company Overview 162
9.12 Immucor, Inc. 162
9.12.1 Company Overview 162
10 Haematology Market Pipeline Products 163
11 Recent Developments 164
11.1 Financial Announcements 164
11.1.1 Jun 05, 2015: InVivo Therapeutics Announces Enrollment of Third Patient in Pilot Spinal Cord Injury Trial 164
11.1.2 Jun 04, 2015: Guided Therapeutics Awarded Multiple Tenders for LuViva Advanced Cervical Scan Systems from Governments in Bangladesh 164
11.1.3 Jun 04, 2015: Philips debuts Alice NightOne at-home sleep disorder diagnostic system 165
11.1.4 Jun 04, 2015: FDA Clears NovaBay Pharmaceuticals' New High-Tech Device, intelli-Case, for Safely Disinfecting Contact Lenses with Hydrogen Peroxide 166
11.1.5 Jun 04, 2015: Roche receives FDA clearance for the cobas Cdiff Test to detect Clostridium difficile 167
11.1.6 May 15, 2015: Data Shows Improved Outcomes for Patients With St. Jude Medical Quadripolar CRT-P System 168
11.1.7 May 11, 2015: Shionogi Reports Net Sales Of JPY274 Billion In Fiscal 2015 170
11.1.8 Feb 02, 2015: Shionogi Reports Net Sales Of JPY200.3 Billion For The Nine Months Ended December 31, 2014 170
11.1.9 Oct 29, 2014: SHIONOGI Announces Consolidated Financial Results For The Second Quarter Of Fiscal Year 2014 170
11.1.10 Oct 10, 2014: Edan Introduces Acclarix Compact Ultrasound System at ANESTHESIOLOGY2014 171
11.2 Legal And Regulatory 173
11.2.1 Feb 15, 2015: Sysmex Philippines achieves ISO9001:2008 Certification 173
11.3 Other Significant Developments 174
11.3.1 Aug 18, 2015: Ortho Clinical Diagnostics Selects Model N for Global Deployment of Revvy Configure Price Quote for Medical Technologies 174
11.4 Strategy And Business Planning 174
11.4.1 Jul 07, 2015: Shionogi Announces the Continued Expansion of their Operations in Europe with the Launch of Shionogi Italy 174
12 Appendix 176
12.1 Research Methodology 177
12.1.1 Coverage 177
12.1.2 Secondary Research 177
12.1.3 Primary Research 178
12.1.4 Company Share Analysis 178
12.1.5 Distribution Share Analysis 178
12.2 GlobalData Consulting 178
12.3 Contact Us 178
12.4 Disclaimer 179

1.1 List of Tables
Table 1: Haematology Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021 15
Table 2: Haematology Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021 17
Table 3: Haematology Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014 19
Table 4: Haematology Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021 21
Table 5: Haematology Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2014 23
Table 6: Haematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 25
Table 7: Haematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 27
Table 8: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 29
Table 9: Haematology Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 31
Table 10: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 33
Table 11: Haemostasis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 35
Table 12: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 37
Table 13: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Table 14: Haematology Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 41
Table 15: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 43
Table 16: Haemostasis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 45
Table 17: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Table 18: Haematology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 48
Table 19: Haematology Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 50
Table 20: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 52
Table 21: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 54
Table 22: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 56
Table 23: Haematology Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 58
Table 24: Haematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 60
Table 25: Haemostasis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 62
Table 26: Immunohaematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 64
Table 27: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 66
Table 28: Haematology Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Table 29: Haematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 70
Table 30: Haemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 72
Table 31: Immunohaematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 74
Table 32: Haematology Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 75
Table 33: Haematology Market, China, Company Share by Revenue ($m), USD Constant, 2014 77
Table 34: Haematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 79
Table 35: Haematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 81
Table 36: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 83
Table 37: Haematology Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 85
Table 38: Haematology Reagents Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 87
Table 39: Haemostasis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 89
Table 40: Immunohaematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 91
Table 41: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Table 42: Haematology Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Table 43: Haematology Reagents Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Table 44: Haemostasis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 99
Table 45: Immunohaematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 101
Table 46: Haematology Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014 102
Table 47: Haematology Market, India, Company Share by Revenue ($m), USD Constant, 2014 104
Table 48: Haematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 106
Table 49: Haematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 108
Table 50: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 110
Table 51: Haematology Rapid Tests and POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 112
Table 52: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 114
Table 53: Haemostasis Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 116
Table 54: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 118
Table 55: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 120
Table 56: Haematology Rapid Tests and POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 122
Table 57: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 124
Table 58: Haemostasis Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 126
Table 59: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 128
Table 60: Haematology Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 129
Table 61: Haematology Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 131
Table 62: Haematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 133
Table 63: Haematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 135
Table 64: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 137
Table 65: Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 139
Table 66: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 141
Table 67: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 143
Table 68: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 145
Table 69: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 147
Table 70: Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 149
Table 71: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 151
Table 72: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 153
Table 73: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 155
Table 74: Haematology Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014 156
Table 75: Haematology Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 158
Table 76: Haematology Market Pipeline Products 163

1.2 List of Figures
Figure 1: Haematology Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021 14
Figure 2: Haematology Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021 16
Figure 3: Haematology Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014 18
Figure 4: Haematology Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021 20
Figure 5: Haematology Market, Asia-Pacific, Company Share (%) 2014 22
Figure 6: Haematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 24
Figure 7: Haematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 26
Figure 8: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 28
Figure 9: Haematology Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 30
Figure 10: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 32
Figure 11: Haemostasis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 34
Figure 12: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 36
Figure 13: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Figure 14: Haematology Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 40
Figure 15: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 42
Figure 16: Haemostasis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 44
Figure 17: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 46
Figure 18: Haematology Market, Australia, Company Share (%) 2014 49
Figure 19: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 51
Figure 20: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 53
Figure 21: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 55
Figure 22: Haematology Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 57
Figure 23: Haematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 59
Figure 24: Haemostasis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 61
Figure 25: Immunohaematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 63
Figure 26: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 65
Figure 27: Haematology Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 67
Figure 28: Haematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 69
Figure 29: Haemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 71
Figure 30: Immunohaematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 73
Figure 31: Haematology Market, China, Company Share (%) 2014 76
Figure 32: Haematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 78
Figure 33: Haematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 80
Figure 34: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 82
Figure 35: Haematology Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 84
Figure 36: Haematology Reagents Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 86
Figure 37: Haemostasis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 88
Figure 38: Immunohaematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 90
Figure 39: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Figure 40: Haematology Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Figure 41: Haematology Reagents Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Figure 42: Haemostasis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Figure 43: Immunohaematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 100
Figure 44: Haematology Market, India, Company Share (%) 2014 103
Figure 45: Haematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 105
Figure 46: Haematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 107
Figure 47: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 109
Figure 48: Haematology Rapid Tests and POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 111
Figure 49: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 113
Figure 50: Haemostasis Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 115
Figure 51: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 117
Figure 52: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 119
Figure 53: Haematology Rapid Tests and POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 121
Figure 54: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 123
Figure 55: Haemostasis Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 125
Figure 56: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 127
Figure 57: Haematology Market, Japan, Company Share (%) 2014 130
Figure 58: Haematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 132
Figure 59: Haematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 134
Figure 60: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 136
Figure 61: Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 138
Figure 62: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 140
Figure 63: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 142
Figure 64: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 144
Figure 65: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 146
Figure 66: Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 148
Figure 67: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 150
Figure 68: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 152
Figure 69: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 154
Figure 70: Haematology Market, South Korea, Company Share (%) 2014 157

Companies mentioned
Sysmex Corporation
Siemens Healthcare
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Horiba, Ltd.
Abbott Laboratories
Nihon Kohden Corporation
Transasia Bio-Medicals Ltd.
Mindray Medical International Limited
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Immucor, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.